Disease Info Card

Heterotopic Ossification

Information about Heterotopic Ossification: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Heterotopic Ossification

Most recent studies have shown that Heterotopic Ossification shares some biological mechanisms with ankylosis, arthritis, arthropathy, bone-diseases, brain-injuries, calcinosis, compression-of-spinal-cord, degenerative-polyarthritis, dislocations, fibrodysplasia-ossificans-progressiva, fracture, metaplasia, myositis-ossificans, neoplasms, osseous-metaplasia, ossification-of-posterior-longitudinal-ligament, pain, spinal-cord-diseases, spinal-cord-injuries, spinal-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Heterotopic Ossification, and have been seen in publications frequently: Aging, Angiogenesis, Bone Development, Bone Remodeling, Bone Resorption, Cell Differentiation, Cell Proliferation, Endochondral Ossification, Excretion, Inflammatory Response, Intramembranous Ossification, Localization, Metaplastic Ossification, Ossification, Osteoblast Differentiation, Pathogenesis, Reflex, Regeneration, Transposition, Wound Healing

Quite a number of genes have been found to play important roles in Heterotopic Ossification, such as ACVR1, ARC, BGLAP, BMP2, BMP4, BMP7, CHTOP, COL6A1, FGFR1OP, GNAS, HHIP, HMOX1, NOL3, PTH, REG3A, RPL29, RUNX2, SPP1, ST13. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.